These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dietary control of hyperlipoproteinemia. Lacatîs D; Bălan M; Creţeanu G Med Interne; 1980; 18(1):49-53. PubMed ID: 7375800 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of lipoprotein disorders. Lloyd JK Ric Clin Lab; 1982; 12(1):97-100. PubMed ID: 7089428 [No Abstract] [Full Text] [Related]
10. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard]. Schwartzkopff W; Schilling A; Calder D Med Welt; 1980 Apr; 31(14):515-20. PubMed ID: 7374415 [No Abstract] [Full Text] [Related]
12. Defenestration of hepatic sinusoids in the pathogenesis of alcoholic hyperlipoproteinemia. Scheig R Hepatology; 1990 Jan; 11(1):148-9. PubMed ID: 2295466 [No Abstract] [Full Text] [Related]
13. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G; Fragiacomo C; Weidmann P; Bachmann C Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660 [TBL] [Abstract][Full Text] [Related]
14. [Nutrition and dyslipoproteinemias based on data from 3 years' prospective observation]. Verbitskaia AI; Kuts GG Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(2):111. PubMed ID: 4063079 [No Abstract] [Full Text] [Related]
15. [Hyperlipoproteinemia. Epidemiology, etiology, physiopathology, diagnosis, diet and drug therapy]. Moulin P; Berthezène F Rev Prat; 1995 Jun; 45(12):1546-54. PubMed ID: 7660012 [No Abstract] [Full Text] [Related]